Navigation Links
Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents
Date:11/12/2013

Charlotte, NC (PRWEB) November 12, 2013

CHARLOTTE, NC, Nov 8, 2013 /PRWeb/ -- Countervail Corporation announced today the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised a contract option for an additional $5.4 million for the further development of galantamine hydrobromide, under the trade name AverTox™, as a medical countermeasure to the toxic effects of organophosphorus based nerve agents. BARDA exercised the option following an inter-agency In Process Review of the performance milestones completed by the company during the first phase of the contract.

“AverTox™ has shown favorable laboratory results as a neuroprotectant against the toxic effects of nerve agents such as Sarin and VX. We are pleased to have the continued support from BARDA for the development of this promising drug,” said CEO and President of Countervail, Bill Basinger.

Countervail has the distinction of being the first company awarded a contract with BARDA for the development of a medical countermeasure to a chemical threat. To date, the company has been awarded $10.7 million under the five-year $24.9 million contract.

About Countervail Corporation
Countervail Corporation, formed in 2007, is an early stage biopharmaceutical company focused on the development and commercialization of products that protect our military and civilian populations from chemical and biological threats.

This project has been funded in whole or in part with federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, under Contract No: HHSO100201100030C

Read the full story at http://www.prweb.com/releases/2013/11/prweb11317764.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Agein Corporation, a Leading Anti-Aging Company, Responds to Research Showing More Men Turning to Cosmetic Surgery to Increase Work Opportunities
2. Rich Products Corporation Streamlines their Production Process with Seamless Workflow, Media Asset Management and Online Proofing
3. ZeptoMetrix Corporation (ZMC) in Collaboration with CytoSignet, Inc. to Offer Proactive, Patented* and Extensive Bed Bug Detection Products
4. Divine Corporation, Developers of Divine 9 Personal Lubricants with Carragel, Changes the Company Name to CarraShield Labs, Inc.
5. Agein Corporation Congratulates Wal-Mart & Target for Ban of Chemicals in Products
6. E-Waste Event, Hosted by: Miller Recycling Corporation
7. Pionetics® Corporation Signs Rayne of Amarillo as a New LINX® Distributor
8. Vidacare Corporation Launches New iOS App for OnControl Powered Bone Access System
9. Evaero Corporation to Participate in National Conference on Addiction Disorders
10. Domtar Corporation to Locate North American Operations Center in Pitt County, NC
11. Scientific Technologies Corporation Featured on 21st Century Health Television Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: